explore -WSS

explore

author：fashion 2025-09-28 00:53:05 - browse：76

Photo of an arrangement of aspirin pills — Patrick Sison/AP

Low-dose aspirin led to a reduction in liver fat among patients with metabolic-associated liver disease, a small study out of Boston found.

The clinical trial, led by Tracey Simon of Massachusetts General Hospital and Harvard Medical School, compared two groups of patients with metabolic dysfunction-associated steatotic liver disease, or MASLD. One group was given baby aspirin daily for six months, while the other received a placebo pill. At the end of the study period, the aspirin group had reduced hepatic fat content while the placebo group had higher fat buildup.

MASLD (formerly known as non-alcoholic fatty liver disease) is a growing health threat, with 1 in 3 Americans having a troublesome amount of fat in their liver. The lipid buildup feeds into a toxic cycle of inflammation, tissue damage and, ultimately, irreversible scarring.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Amylyx ALS drug failure raises questions and concerns

explore

WSS

What affirmative action's end means to a medical student

UpToDate has a racism problem: Dr. Stanley Goldfarb

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Novo Nordisk obesity pill bests Wegovy in early trial

STAT wants to know your pick for a great summer read or listen

Sen. Paul opposes bill to ban Chinese biotechs

focus

explore

hotspot

Peter Hotez and the public health issue of online harassment

Canadians with cystic fibrosis outlive Americans by a decade

In age of alternative facts, a scholarly course on calling out crap

Canadians with cystic fibrosis outlive Americans by a decade

Dobbs anniversary: the lost opportunity of abortion as health care

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Amylyx ALS drug fails large clinical trial

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Readout: Amylyx, Alumis, and Lundbeck drug updates

explore

Fatty liver disease was alleviated by Lilly’s ‘triple

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Undocumented workers face uncertainty as immigration law takes effect in Florida

'Screen and refer' systems are hurting patients

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Dexcom's push to bring CGM to type 2 diabetes patients

hotspot

focus

explore

hotspot